Integrating network pharmacology and in silico analysis deciphers Withaferin-A’s anti-breast cancer potential via hedgehog pathway and target network interplay

Author:

Srinivasan Mythili1ORCID,Gangurde Apeksha2,Chandane Ashwini Y3,Tagalpallewar Amol2,Pawar Anil2,Baheti Akshay M2ORCID

Affiliation:

1. Research Scholar, School of Health Sciences and Technology, Dr. Vishwanath Karad MIT World Peace University , Pune, Maharashtra 411038 , India

2. School of Health Sciences and Technology, Dr. Vishwanath Karad MIT World Peace University , Pune, Maharashtra 411038 , India

3. Abhinav College of Pharmacy , Narhe, Ambegaon, Pune, Maharashtra 411041 , India

Abstract

Abstract This study examines the remarkable effectiveness of Withaferin-A (WA), a withanolide obtained from Withania somnifera (Ashwagandha), in encountering the mortiferous breast malignancy, a global peril. The predominant objective is to investigate WA’s intrinsic target proteins and hedgehog (Hh) pathway proteins in breast cancer targeting through the application of in silico computational techniques and network pharmacology predictions. The databases and webtools like Swiss target prediction, GeneCards, DisGeNet and Online Mendelian Inheritance in Man were exploited to identify the common target proteins. The culmination of the WA network and protein–protein interaction network were devised using Stitch and String web tools, through which the drug–target network of 30 common proteins was constructed employing Cytoscape-version 3.9. Enrichment analysis was performed by incorporating Gprofiler, Metascape and Cytoscape plugins. David compounded the Gene Ontology and Kyoto Encyclopedia of Genes and Genomes, and enrichment was computed through bioinformatics tools. The 20 pivotal proteins were docked harnessing Glide, Schrodinger Suite 2023-2. The investigation was governed by docking scores and affinity. The shared target proteins underscored the precise Hh and WA network roles with the affirmation enrichment P-value of <0.025. The implications for hedgehog and cancer pathways were profound with enrichment (P < 0.01). Further, the ADMET and drug-likeness assessments assisted the claim. Robust interactions were noticed with docking studies, authenticated through molecular dynamics, molecular mechanics generalized born surface area scores and bonds. The computational investigation emphasized WA’s credible anti-breast activity, specifically with Hh proteins, implying stem-cell-level checkpoint restraints. Rigorous testament is imperative through in vitro and in vivo studies.

Publisher

Oxford University Press (OUP)

Reference56 articles.

1. Breast cancer statistics, 2022;Giaquinto;CA Cancer J Clin,2022

2. Cancer statistics, 2023;Siegel;CA Cancer J Clin,2023

3. Global cancer statistics 2022: the trends projection analysis;Chhikara;Chem Biol Lett,2023

4. Anticancer cytotoxicity and antifungal abilities of green-synthesized cobalt hydroxide (co(OH)2) nanoparticles using Lantana camara L;Ravi;Beni-Suef Univ J Basic Appl Sci,2022

5. Withaferin A: from ancient remedy to potential drug candidate;Sultana;Molecules,2021

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3